Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline
Author:
Publisher
Frontiers Media SA
Subject
Immunology,Immunology and Allergy
Reference27 articles.
1. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China;Porcheddu;J Infect Dev Ctries,2020
2. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020
3. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China;Ruan;Intensive Care Med,2020
4. Coronavirus disease 2019 (COVID-19) and immune-engaging cancer treatment;Abid;JAMA Oncol.,2020
5. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet;Zhou,2020
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Alterations in Gut Microbiota Composition in Patients with COVID-19: A Pilot Study of Whole Hypervariable 16S rRNA Gene Sequencing;Biomedicines;2023-01-27
2. Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients;Frontiers in Oncology;2022-12-20
3. Gut microbiome and anti-viral immunity in COVID-19;Critical Reviews in Food Science and Nutrition;2022-11-16
4. Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipients – targeting the target antigen;Bone Marrow Transplantation;2022-08-26
5. SARS-CoV-2 Variants, Vaccines, and Host Immunity;Frontiers in Immunology;2022-01-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3